Top Stories

Ride-hailing company Lyft introduced a new monthly subscription plan that offers free or discounted rides for a price of $299 every 30 days. Passengers can subscribe to the monthly plan, starting today. It will be available to everyone in the U.S....


A report released by the National Association of Home Builder on Tuesday unexpectedly showed a modest increase in U.S. homebuilder confidence in the month of October. The report said the NAHB/Wells Fargo Housing Market Index inched up to 68 in October...


Continuing a record fundraising streak, President Donald Trump's campaign for re-election in 2020 brought in more than $18 million in the third quarter. Trump's campaign said the more than $18 million raised in the July-September period came in both...


After moving notably higher early in the session, stocks have seen further upside over the course of the trading day on Tuesday. The major averages have moved sharply higher after ending the previous session firmly in the red.


Taylor Swift stole the 2018 American Music Awards night with a crowd-pumping show opening performance, followed by breaking the record for most AMA wins ever by a female artist. Winning four trophies each, she was the topper at this year along with...

wallstreet-sept27_09oct18.jpg Stocks fluctuated over the course of the trading day on Tuesday, extending the volatile performance seen in the previous session. The major averages spent the session bouncing back and forth across the unchanged line before closing mixed for the second straight day.
pharma-021717_09oct18.jpg The following are some of today's top gainers in the pharma/biotech sector.
pharma-011017_09oct18.jpg The following are some of the pharma/biotech stocks that posted the biggest percentage decline today.
asian-up_09oct18.jpg Asian stock markets are mostly lower on Wednesday with investors treading cautiously following the mixed cues from Wall Street amid lingering worries about the impact of rising interest rates and U.S.-China tensions. Investors also digested U.S. President Donald Trump's comments that he did not like the Federal Reserve's decision to continue raising interest rates.
Read More
trump-thumb-101618.jpg Continuing a record fundraising streak, President Donald Trump's campaign for re-election in 2020 brought in more than $18 million in the third quarter. Trump's campaign said the more than $18 million raised in the July-September period came in both...
Read More
elizabeth-warren-101518.jpg Seeking defuse frequent attacks by President Donald Trump, Democratic Senator Elizabeth Warren, D-Mass., released the results of a DNA test on Monday that support her claims of Native American ancestry.
Read More
The Swiss stock market posted modest gains in early trade Tuesday and rose steadily throughout the second half of the day. The market ended the day with a substantial gain on broad strength. Investors were encouraged by the recovery on Wall Street Tuesday, after better than expected earnings reports...
The Goldman Sachs Group, Inc. (GS) reported earnings per common share of $6.28 for the third quarter of 2018 compared to $5.02 for the third quarter of 2017. On average, 22 analysts polled by Thomson Reuters expected the company to report profit per share of $5.38 for the quarter. Analysts' estimates...
Read More
Bitcoin payment processor BitPay will now start providing merchants and businesses the option to receive the settlement for their payments using two recently launched stable coins - Gemini Dollars (GUSD) and Circle USD Coin (USDC).The ERC20-based stable coins, issued by regulated cryptocurrency exchanges Gemini and Circle, are backed 1:1 by the value of US dollars and held at FDIC insured banks. Read More
As we head into another month of new drug approvals, it's time to take a look at some of the FDA-related news that grabbed headlines in September. Seeking to curb the sharp rise in the number of teens using e-cigarettes, the FDA, has expanded its Youth Tobacco Prevention Plan, which was first introduced last April. Read More
Allergan plc (AGN) and Medicines360, a global nonprofit women's health pharmaceutical company with a mission of expanding access to quality medicines, said that the U.S. Food and Drug Administration approved Medicines360's Supplemental New Drug Application... Read More
Follow RTT
Economic Calendar
10/16/18 10:0Official Foreign ReservesOCT 12 Mexico
10/16/18 10:0CB Leading IndexSEP Brazil
10/16/18 10:0CB Coincidence IndexSEP Brazil
10/16/18 10:0NAHB/Wells Fargo Housing Market IndexOCT United States
10/16/18 9:15Capacity Utilization (M-o-M)SEP United States
10/16/18 9:15Industrial Production (Y-o-Y)SEP United States
View All
FDA Calendar
Event DateSymbolDrug NameEvent Name
01/05/19ACORINBRIJA (NDA)FDA decision on INBRIJA as a treatment for symptoms of OFF periods in people with Parkinson’s disease taking a carbidopa/levodopa regimen.
12/31/18PTLAAndexxa Prior Approval Supplement FDA decision on Andexxa for patients treated with rivaroxaban and apixaban, when reversal of anticoagulation is needed
12/24/18RHHBYBaloxavir Marboxil (NDA)FDA decision on Baloxavir Marboxil for the treatment of acute, uncomplicated influenza in people 12 years and older
12/21/18SHPG, SHP.LPrucalopride (NDA)FDA decision on Prucalopride as a potential once-daily treatment option for chronic idiopathic constipation in adults
12/20/18JAZZSolriamfetol (NDA)FDA decision on Solriamfetol for the treatment of excessive sleepiness in adult patients with narcolepsy or obstructive sleep apnea
View All